Portfolio Update

Finsbury Worldwide Pharm Tst PLC
04 January 2006



                                                                  4 January 2006


                    FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
                                   (the 'Company')


                       QUARTERLY STATEMENT OF INVESTMENTS

In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:

  • Investments valuing greater than 5% of the Company's gross assets comprise
    the following:

Company Name                                                        Value of Investment at      % of Total
                                                                       31 December 2005     Portfolio Assets

Genentech Inc Com Stk USD 0.02 NPV                                        26,401,631               7.64
Novartis CHF 0.50 REGD                                                    25,451,870               7.37
Amgen Com USD 0.0001                                                      19,522,645               5.65
Serono SA 'B' CHF25                                                       18,465,482               5.34

  • The ten largest investments held by the Company comprise the following:


Company Name                                                         Value of Investment at      % of Total
                                                                        31 December 2005    Portfolio Assets

Genentech Inc Com Stk USD 0.02 NPV                                         26,401,631               7.64
Novartis CHF 0.50 REGD                                                     25,451,870               7.37
Amgen Com SUD 0.0001                                                       19,522,645               5.65
Serono SA 'B' CHF25                                                        18,465,482               5.34
Johnson & Johnson Com USD 1                                                17,013,893               4.92
Genzyme Corp General Division Com USD 0.01                                 14,553,860               4.21
Wyeth Com USD 0.333                                                        14,410,712               4.17
Medimmune Inc Com USD 0.01                                                 14,034,519               4.06
Gen-Probe Inc USD 0.0001                                                   13,925,790               4.03
Lilly (Eli) & Company Com USD NPV                                          13,844,648               4.01


                                    - ENDS -

For further information please contact:
Tracey Lago, Company Secretary
Close Finsbury Asset Management Limited
Telephone: [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange